A pairing appears on this page only when a trial gave both ingredients together and measured the result. Thaumatin has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Steviol glycosides such as rebaudioside A carry a bitter and metallic tail that many people notice several seconds after tasting. Thaumatin is used at sub-sweetening levels as a flavour modifier that suppresses that tail. This is routine in beverage and supplement flavour work. Thaumatin has its own slow onset and licorice-like character, so the ratio has to be kept low or it becomes the dominant note.
Sucralose delivers a fast clean sweetness that fades quickly, while thaumatin is slow to arrive and lingers. Combining the two gives a curve closer to sugar than either produces on its own. The pairing is formulation convention in low-calorie drinks. Overdosing thaumatin extends the aftertaste well beyond what most people want.
Protein hydrolysates release hydrophobic peptides that bind bitter taste receptors, which is why unflavoured protein powders taste harsh. Thaumatin acts as a bitterness blocker at concentrations below its sweetening threshold. The effect is on perception, not on the protein itself. It does not change amino acid content or digestibility.
Berberine is intensely bitter and difficult to put into a chewable or powder format. Thaumatin at low inclusion suppresses bitter receptor signalling and makes such formats workable. This is a palatability question and nothing else. It has no bearing on berberine absorption or activity.
Thaumatin is a 207 amino acid polypeptide, and its sweetness depends on intact tertiary structure held by eight disulfide bridges. Protease activity in a formula, whether from added enzymes or from raw plant material, cleaves it and destroys the sweetness. This is a real manufacturing constraint in enzyme-containing powders. The interaction is inside the product, not in the body.
Bromelain is a cysteine protease active over a broad pH range, and thaumatin is an ordinary protein substrate for it. In a dry blend with low water activity nothing happens, but once the product is reconstituted the sweetness can fade within minutes. The same applies to papain and to pancreatin. Formulators either separate the two or accept the loss.
Papain cleaves peptide bonds without much sequence specificity, so a sweet protein in the same liquid is a target like any other. Loss of the folded structure means loss of the sweet taste, since sweetness comes from surface topology rather than from any small fragment. Dry blends are stable. Anything wet is not.
Root extracts standardised on withanolides carry a strong bitter and earthy character that is hard to cover with sweetness alone. Thaumatin suppresses the bitter component rather than simply piling sugar over it. The pairing is a formulation choice for chewables and drink mixes. It changes nothing about the extract's constituents.
Caffeine is a classic bitter stimulus and is used as the reference bitterant in sensory testing. Thaumatin at sub-sweetening levels reduces perceived bitterness, which is why it appears in energy formats. The interaction is on the tongue. It does not alter caffeine absorption or effect.
Nothing specific on file for Thaumatin. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 2 we read for Thaumatin. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.